Yatharth Hospitals Q1FY27 Revenue Surges 51% YoY to ₹3,927 Million
Yatharth Hospital reported Q1 FY27 revenue of ₹3,927 million, up 51% YoY. EBITDA grew 39% YoY to ₹917 million. PAT was ₹454 million. The company is expanding capacity with a new 250-bed hospital in Gurugram, targeting ~5,000 beds in 3 years. An interim dividend of 5% was announced.
The substantial revenue and EBITDA growth, coupled with strategic expansion plans and new facility achievements, are material positive developments for the company's financial health and future prospects.
The company reported significant year-on-year growth in revenue and EBITDA, along with operational milestones like EBITDA breakeven at a new facility, indicating strong business performance and positive outlook.
Yatharth Hospital & Trauma Care Services Limited has announced its financial results for the first quarter of FY27, reporting a significant year-on-year revenue growth of 51%. The company's revenue from operations reached ₹3,927 million, a notable increase from ₹2,592 million in Q1 FY26. This growth was also substantial on a quarter-on-quarter basis, with a 15% increase from ₹3,416 million in Q4 FY26.
EBITDA for the quarter also saw robust growth, rising by 39% year-on-year to ₹917 million, up from ₹660 million in Q1 FY26. Sequentially, EBITDA increased by 15% from ₹799 million in Q4 FY26. The consolidated EBITDA margin stood at 23.3%. The adjusted EBITDA margin, excluding ramp-up losses from newer hospitals, was a strong 28.1%.
Profit After Tax (PAT) for the quarter was ₹454 million, an 8.0% increase compared to ₹420 million in the same period last year. However, the PAT margin saw a decrease to 11.6% from 16.2% in Q1 FY26, attributed to higher depreciation and tax expenses.
The company also highlighted operational achievements, including its Faridabad Sector-20 facility achieving EBITDA breakeven in a record nine months and the Agra hospital reporting an EBITDA margin exceeding 20% in its first full quarter of integration. The Model Town, New Delhi facility is also ramping up strongly, with ARPOB approaching ₹50,000.
Further strategic initiatives include the approval of an ESOP grant to employees and the launch of a new ESOP Scheme 2026 to attract and retain talent. The company also announced its first interim dividend of 5% of the face value.
Yatharth Hospital is also expanding its bed capacity, with an under-construction, ultra-modern super-speciality hospital in Gurugram, Sector 40. This 250-bedded facility, a 100% stake acquisition costing ₹100 crore, is expected to commence operations by Q1 FY28, with a proposed total outlay of ₹200 crore.
The company aims to scale its capacity to approximately 5,000 beds within the next three years, supported by a clear roadmap for capacity expansion through greenfield and brownfield projects, as well as strategic acquisitions.
What to do with a filing like this
Yatharth Hospital & Trauma Care Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Yatharth Hospital & Trauma Care Services Limited. Read the original for the full detail.